Abstract | PURPOSE: METHODS AND MATERIALS: Adult patients who had histologically confirmed malignant glioma that had progressed after surgery and external beam radiotherapy were eligible for this Phase I study, provided that >6 months had elapsed from the last date of radiation therapy. The first 10 patients received a fixed dose, 290 mg/kg, of L-boronophenylalanine- fructose (L- BPA-F) as a 2-hour infusion before neutron irradiation, and the remaining patients were treated with escalating doses of L- BPA-F, either 350 mg/kg, 400 mg/kg, or 450 mg/kg, using 3 patients on each dose level. Adverse effects were assessed using National Cancer Institute Common Toxicity Criteria version 2.0. RESULTS: Twenty-two patients entered the study. Twenty subjects had glioblastoma, and 2 patients had anaplastic astrocytoma, and the median cumulative dose of prior external beam radiotherapy was 59.4 Gy. The maximally tolerated L- BPA-F dose was reached at the 450 mg/kg level, where 4 of 6 patients treated had a grade 3 adverse event. Patients who were given >290 mg/kg of L- BPA-F received a higher estimated average planning target volume dose than those who received 290 mg/kg (median, 36 vs. 31 Gy [W, i.e., a weighted dose]; p = 0.018). The median survival time following BNCT was 7 months. CONCLUSIONS:
|
Authors | Leena Kankaanranta, Tiina Seppälä, Hanna Koivunoro, Petteri Välimäki, Annette Beule, Juhani Collan, Mika Kortesniemi, Jouni Uusi-Simola, Petri Kotiluoto, Iiro Auterinen, Tom Serèn, Anders Paetau, Kauko Saarilahti, Sauli Savolainen, Heikki Joensuu |
Journal | International journal of radiation oncology, biology, physics
(Int J Radiat Oncol Biol Phys)
Vol. 80
Issue 2
Pg. 369-76
(Jun 01 2011)
ISSN: 1879-355X [Electronic] United States |
PMID | 21236605
(Publication Type: Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- 4-boronophenylalanine-fructose
- Boron Compounds
- Radiation-Sensitizing Agents
- Fructose
|
Topics |
- Adult
- Aged
- Astrocytoma
(mortality, pathology, radiotherapy, surgery)
- Boron Compounds
(administration & dosage, adverse effects, therapeutic use)
- Boron Neutron Capture Therapy
(adverse effects, methods, mortality)
- Brain Neoplasms
(mortality, pathology, radiotherapy, surgery)
- Disease Progression
- Female
- Fructose
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
- Glioblastoma
(mortality, pathology, radiotherapy, surgery)
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Radiation-Sensitizing Agents
(adverse effects, therapeutic use)
- Radiotherapy Dosage
- Young Adult
|